@FierceBiotech: First on Fierce: Eyeing an IPO, Zymeworks partners up with Celgene on bispecifics. Report | Follow @FierceBiotech
@JohnCFierce: Gene therapy pioneer ReGenX fuels R&D, hiring spree with $30M VC round. Article | Follow @JohnCFierce
@DamianFierce: "Precision medicine" about to get stuffed into 100K bio PRs. "Our precision medicine immunotherapy, with applications in NASH and Ebola ..." | Follow @DamianFierce
> Bristol-Myers Squibb ($BMY) Chief Operating Officer Giovanni Caforio will take over the top spot on May 5 when CEO Lamberto Andreotti will step down and serve as executive chairman of the board. News
> Keryx Biopharmaceuticals ($KERX) is raising $100 million in a stock offering, raising cash to commercialize Auryxia, its treatment for chronic kidney disease. More
> AbbVie ($ABBV) has cut the ribbon on an R&D center on the University of Illinois campus, recruiting grad students to participate in data-minded projects. More
Medical Device News
@FierceMedDev: ICYMI yesterday: Samsung, Welch Allyn back $20M round for contact-free monitoring startup EarlySense. Article | Follow @FierceMedDev
@VarunSaxena2: Bill introduced in Congress to simplify marketing of 'research use only' devices and diagnostics. Story | Follow @VarunSaxena2
@EmilyWFierce: Abbott Labs continues Dx winning streak with bladder cancer biomarker deal. Article | Follow @EmilyWFierce
> Cheetah Medical reveals promising study results for noninvasive blood monitoring tech. News
> Hospira gets FDA nod for wireless infusion pump, finishing up two-year plan to reinvigorate devices. Story
Pharma News
@FiercePharma: Law firms trolling for shareholders to sue Sanofi over alleged kickbacks. News | Follow @FiercePharma
@CarlyHFierce: Depomed drawing on digital savvy--and 250 reps--to relaunch Nucynta franchise. Story | Follow @CarlyHFierce
> Actavis CEO: Pharma believer and Botox user, yes. The Borg? No. More
> Salix Pharmaceuticals eyeing sale in wake of corporate fallout. Article
Drug Delivery News
> Celator's delivery platform results in FDA's fast-track designation for its cancer candidate. Report
> U. Arizona team looks to bring GI delivery vehicle to market. More
> 'Micromotors' made of zinc and polymer actively release drugs at stomach lining. Story
> BD must still pay $350M+ due to safety syringe spat; other punishments delayed pending appeal. Article
> India's Piramal to buy U.S. maker of sterile injectables, antibody drug conjugates. News
Diagnostics News
> Abbott Labs continues Dx winning streak with bladder cancer biomarker deal. More
> SV Bio changes name to Lifecode, plans rollout of NGS cancer assay. Story
> Protein analysis method could act as new cancer biomarker. More
> DNA Electronics snags nanoMR for $24M to gain ground in sepsis market. Story
> GenomeDx expands prostate cancer Dx reach with Medicare coverage deal. Article
Pharma Marketing News
> Depomed drawing on digital savvy--and 250 reps--to relaunch Nucynta franchise. Story
> Embattled Salix hires bankers to weigh a potential sale. More
> J&J eyes long-acting boost for Invega franchise with quick FDA look at new formula. Report
> Lilly snares formulary spots for diabetes meds, no pricing war necessary. Story
> Eisai's copay offer on Belviq has unintended consequences for Arena. Article